GlassScriptPhysician profile
Butchaiah Garlapati
NPI 1326035163
$9,152.04
in general payments reported to CMS, 2019-2025
37 companies · $183 in 2025
The $183 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,952 · 2020: $223 · 2021: $2,381 · 2022: $374 · 2023: $1,180 · 2024: $2,858 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,806 · Food and Beverage: $1,415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,805.86 |
| Food and Beverage | $1,415.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $2,407.88 | 2023-2024 | Evoke, Evoke Scs |
| Spinal Simplicity, LLC | $1,940.71 | 2021 | |
| Vertiflex, INC. | $1,364.44 | 2019 | |
| Relievant Medsystems, INC. | $888.60 | 2023 | Intracept |
| Abbott Laboratories | $456.45 | 2019-2025 | Proclaim, Octrode |
| Collegium Pharmaceutical, INC. | $291.43 | 2019-2024 | Xtampza, Belbuca |
| Scilex Pharmaceuticals INC. | $289.39 | 2019-2025 | |
| Abbvie INC. | $251.72 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $138.67 | 2019-2025 | Relistor |
| Horizon Therapeutics Plc | $131.89 | 2019-2022 | |
| Boston Scientific Corporation | $115.86 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Nalu Medical, INC. | $84.48 | 2021-2024 | Nalu Neurostimulation System |
| Si-Bone, INC. | $80.13 | 2019-2020 | |
| Amgen INC. | $74.87 | 2021-2022 | |
| Allergan, INC. | $71.66 | 2019-2022 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $63.01 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $58.36 | 2019-2020 | |
| Lundbeck LLC | $55.90 | 2020-2024 | Vyepti |
| Novartis Pharmaceuticals Corporation | $50.27 | 2019 | |
| Grt US Holding, INC. | $38.56 | 2022 | |
| Daiichi Sankyo INC. | $31.53 | 2019 | |
| Globus Medical, INC. | $29.08 | 2025 | Senza |
| Lilly USA, LLC | $23.83 | 2019-2020 | |
| Biodelivery Sciences International, INC. | $21.03 | 2019 | |
| Biotronik Nro, INC. | $20.18 | 2025 | Prospera |
| Galderma Laboratories, L.P. | $19.62 | 2024 | |
| Hikma Pharmaceuticals USA | $18.79 | 2024 | Kloxxado |
| Nevro Corp. | $18.23 | 2023 | Senza |
| Astrazeneca Pharmaceuticals LP | $18.19 | 2019 | |
| Jazz Pharmaceuticals INC. | $15.64 | 2019 | |
| Alexion Pharmaceuticals, INC. | $12.38 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.07 | 2020 | |
| Arbor Pharmaceuticals, INC. | $11.80 | 2020 | |
| Kaleo, INC. | $11.76 | 2019 | |
| Pfizer INC. | $11.51 | 2019 | |
| Mdd US Operations, LLC | $11.29 | 2019 | |
| Stimwave Technologies Incorporated | $10.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Butchaiah Garlapati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.